Larimar Therapeutics, Inc. LRMR
Set alert
At close · Oct 30
After hours · Oct 30, 4:00 PM ET
- YTD
- -35.17%
- 1 year
- -38.86%
- Open
- 2.64
- Prev close
- 2.67
- Mkt cap
- 256.59M
- Vol
- 781.28K
- Avg vol
- 1.31M
- EPS
- -1.99
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.42
- High
- 2.66
- Forward P/E
- -2.57
- Beta
- 0.71
- Short ratio
- 5.19
- Inst. own
- 106.56%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 6.92
- 200-d avg
- 7.61
- 1y target
- 20.41
5D chart
Signals (53)
| Name | Time | Ago |
|---|---|---|
| RSI: Oversold | Oct 30, 9:40 AM | 1 day ago |
| MACD: Sell Signal | Oct 30, 9:35 AM | 1 day ago |
| SMA: Bearish | Oct 30, 9:30 AM | 1 day ago |
| SMA: Bullish | Oct 29, 3:30 PM | 2 days ago |
| SMA: Bearish | Oct 29, 3:15 PM | 2 days ago |
| SMA: Bullish | Oct 29, 3:10 PM | 2 days ago |
| MACD: Buy Signal | Oct 29, 3:05 PM | 2 days ago |
| MACD: Sell Signal | Oct 29, 12:55 PM | 2 days ago |
| SMA: Bearish | Oct 29, 12:50 PM | 2 days ago |
| MACD: Buy Signal | Oct 29, 11:40 AM | 2 days ago |
| RSI: Overbought | Oct 29, 11:40 AM | 2 days ago |
| SMA: Bearish | Oct 29, 10:50 AM | 2 days ago |
| MACD: Sell Signal | Oct 29, 10:35 AM | 2 days ago |
| SMA: Bearish | Oct 29, 10:25 AM | 2 days ago |
| RSI: Overbought | Oct 29, 10:15 AM | 2 days ago |
| RSI: Overbought | Oct 29, 10:00 AM | 2 days ago |
| RSI: Overbought | Oct 29, 9:30 AM | 2 days ago |
| MACD: Buy Signal | Oct 28, 3:35 PM | 3 days ago |
| SMA: Bullish | Oct 28, 3:30 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 1:40 PM | 3 days ago |
| MACD: Buy Signal | Oct 28, 1:25 PM | 3 days ago |
| SMA: Bullish | Oct 28, 12:30 PM | 3 days ago |
| SMA: Bullish | Oct 28, 12:30 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 11:45 AM | 3 days ago |
| RSI: Overbought | Oct 28, 11:20 AM | 3 days ago |
| RSI: Overbought | Oct 28, 10:40 AM | 3 days ago |
| RSI: Overbought | Oct 28, 10:10 AM | 3 days ago |
| MACD: Buy Signal | Oct 28, 10:05 AM | 3 days ago |
| SMA: Bullish | Oct 28, 9:40 AM | 3 days ago |
| SMA: Bearish | Oct 28, 9:35 AM | 3 days ago |
| SMA: Bearish | Oct 28, 9:30 AM | 3 days ago |
| RSI: Overbought | Oct 27, 3:55 PM | 4 days ago |
| MACD: Sell Signal | Oct 27, 3:50 PM | 4 days ago |
| SMA: Bearish | Oct 27, 3:25 PM | 4 days ago |
| RSI: Overbought | Oct 27, 2:45 PM | 4 days ago |
| MACD: Buy Signal | Oct 27, 2:15 PM | 4 days ago |
| SMA: Bearish | Oct 27, 12:25 PM | 4 days ago |
| SMA: Bullish | Oct 27, 11:35 AM | 4 days ago |
| MACD: Sell Signal | Oct 27, 11:10 AM | 4 days ago |
| RSI: Overbought | Oct 27, 10:15 AM | 4 days ago |
| SMA: Bullish | Oct 26, 3:35 PM | 5 days ago |
| MACD: Buy Signal | Oct 26, 2:50 PM | 5 days ago |
| MACD: Sell Signal | Oct 26, 2:40 PM | 5 days ago |
| MACD: Buy Signal | Oct 26, 2:20 PM | 5 days ago |
| MACD: Sell Signal | Oct 26, 1:45 PM | 5 days ago |
| SMA: Bullish | Oct 26, 1:25 PM | 5 days ago |
| SMA: Bearish | Oct 26, 1:15 PM | 5 days ago |
| SMA: Bullish | Oct 26, 1:00 PM | 5 days ago |
| RSI: Oversold | Oct 26, 12:55 PM | 5 days ago |
| SMA: Bearish | Oct 26, 12:40 PM | 5 days ago |
| SMA: Bullish | Oct 26, 12:15 PM | 5 days ago |
| RSI: Oversold | Oct 26, 11:55 AM | 5 days ago |
| SMA: Bearish | Oct 26, 10:30 AM | 5 days ago |
News
-
1 month ago benzinga.com
Larimar Therapeutics Appoints John Harlow As President and COO, Effective September 29
Larimar Therapeutics, Inc. (Larimar) (NASDAQ:LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced the appointment of John Harlow…
-
2 months ago benzinga.com
Wedbush Maintains Outperform on Larimar Therapeutics, Lowers Price Target to $11
Wedbush analyst Laura Chico maintains Larimar Therapeutics (NASDAQ:LRMR) with a Outperform and lowers the price target from $12 to $11.
-
2 months ago benzinga.com
Larimar Therapeutics Q2 EPS $(0.30) Beats $(0.39) Estimate
Larimar Therapeutics (NASDAQ:LRMR) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.39) by 23.08 percent. This is a 26.83 percent increase over losses…
-
4 months ago benzinga.com
HC Wainwright & Co. Assumes Larimar Therapeutics at Buy, Announces Price Target of $10
HC Wainwright & Co. analyst Raghuram Selvaraju assumes Larimar Therapeutics (NASDAQ:LRMR) with a Buy rating and announces Price Target of $10.
-
4 months ago benzinga.com
Baird Maintains Outperform on Larimar Therapeutics, Lowers Price Target to $5
Baird analyst Joel Beatty maintains Larimar Therapeutics (NASDAQ:LRMR) with a Outperform and lowers the price target from $7 to $5.
4 months ago benzinga.com
Larimar Stock Slides 15% Despite FDA Backing Rolling Submission For Rare Disease Drug
Larimar Therapeutics Inc (LRMR) submits first module of Biologics License Application for investigational treatment for Friedreich's ataxia, with FDA support and positive long-term data showing…
4 months ago benzinga.com
Biohaven, Goodyear Tire And Other Big Stocks Moving Lower In Monday’s Pre-Market Session
US stock futures up, Nasdaq 100 gains 1%. Biohaven (BHVN) shares down after BofA downgrade and enrollment of first patient in phase 3 trial.
4 months ago benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Universe Pharmaceuticals (NASDAQ:UPC) stock moved upwards by 159.6% to $7.68 during Monday's pre-market session. The company's market cap stands at $1.9 million. Decoy Therapeutics…
4 months ago benzinga.com
Why Universe Pharmaceuticals Shares Are Trading Higher By Around 228%; Here Are 20 Stocks Moving Premarket
Universe Pharmaceuticals Inc (NASDAQ: UPC) surged 228.4% to $9.72 in pre-market trading after announcing acquisition of Best Praise International for $10.75 million.
-
4 months ago benzinga.com
Larimar Therapeutics Submits First Module Of Rolling BLA Submission To FDA For Accelerated Approval Of Nomlabofusp; Remaining Modules Expected To Be Submitted In H2 2026
FDA alignment on submission of BLA data package in multi-disciplinary Type B pre-BLA meeting minutes; first module of rolling BLA submitted with remaining modules expected 2H 2026 Daily nomlabofusp…
-
5 months ago benzinga.com
JP Morgan Initiates Coverage On Larimar Therapeutics with Overweight Rating, Announces Price Target of $9
JP Morgan analyst Tessa Romero initiates coverage on Larimar Therapeutics (NASDAQ:LRMR) with a Overweight rating and announces Price Target of $9.
5 months ago benzinga.com
Nvidia To Rally More Than 33%? Here Are 10 Top Analyst Forecasts For Monday
Top analysts changed outlook on top names. Keybanc, Leerink, Wedbush, DA Davidson, Benchmark, Piper Sandler, Morgan Stanley, Evercore raised price targets.
-
5 months ago benzinga.com
Wedbush Maintains Outperform on Larimar Therapeutics, Lowers Price Target to $12
Wedbush analyst Laura Chico maintains Larimar Therapeutics (NASDAQ:LRMR) with a Outperform and lowers the price target from $13 to $12.
-
5 months ago benzinga.com
Larimar Therapeutics Q1 EPS $(0.31) Beats $(0.54) Estimate
Larimar Therapeutics (NASDAQ:LRMR) reported quarterly losses of $(0.31) per share which beat the analyst consensus estimate of $(0.54) by 42.59 percent. This is a 32.61 percent increase over losses…
-
7 months ago benzinga.com
Wedbush Maintains Outperform on Larimar Therapeutics, Raises Price Target to $13
Wedbush analyst Laura Chico maintains Larimar Therapeutics (NASDAQ:LRMR) with a Outperform and raises the price target from $12 to $13.
7 months ago benzinga.com
Earnings Scheduled For March 19, 2026
Earnings Scheduled For March 19, 2026
-
7 months ago benzinga.com
Larimar Therapeutics Q4 EPS $(0.73) Misses $(0.45) Estimate
Larimar Therapeutics (NASDAQ:LRMR) reported quarterly losses of $(0.73) per share which missed the analyst consensus estimate of $(0.45) by 62.22 percent. This is a 62.22 percent decrease over losses…
-
8 months ago benzinga.com
Wedbush Maintains Outperform on Larimar Therapeutics, Raises Price Target to $12
Wedbush analyst Laura Chico maintains Larimar Therapeutics (NASDAQ:LRMR) with a Outperform and raises the price target from $11 to $12.
8 months ago benzinga.com
C3.ai Posts Downbeat Results, Joins Trade Desk, FTAI Aviation And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
C3.ai Posts Downbeat Results, Joins Trade Desk, FTAI Aviation And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
8 months ago benzinga.com
Why Marriott Vacations Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket
Why Marriott Vacations Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket
-
8 months ago benzinga.com
Larimar Therapeutics Commences $75M Common Stock Offering
Larimar Therapeutics, Inc. ("Larimar") (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that it has commenced an…
8 months ago benzinga.com
Laminar Therapeutics Stock Is Popping Today: What's Going On?
Larimar Therapeutics Inc (NASDAQ:LRMR) shares are soaring on Wednesday after multiple analysts reiterated their bullish outlook.
-
8 months ago benzinga.com
Citigroup Maintains Buy on Larimar Therapeutics, Raises Price Target to $14
Citigroup analyst Samantha Semenkow maintains Larimar Therapeutics (NASDAQ:LRMR) with a Buy and raises the price target from $12 to $14.
8 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session
12 Health Care Stocks Moving In Wednesday's Intraday Session
8 months ago benzinga.com
Acadia Healthcare Posts Upbeat Q4 Earnings, Joins Circle Internet, Resideo Technologies And Other Big Stocks Moving Higher On Wednesday
Acadia Healthcare Posts Upbeat Q4 Earnings, Joins Circle Internet, Resideo Technologies And Other Big Stocks Moving Higher On Wednesday
-
8 months ago benzinga.com
Wedbush Reiterates Outperform on Larimar Therapeutics, Maintains $11 Price Target
Wedbush analyst Laura Chico reiterates Larimar Therapeutics (NASDAQ:LRMR) with a Outperform and maintains $11 price target.
8 months ago benzinga.com
Nasdaq Gains Over 1%; Keurig Dr Pepper Earnings Top Views
Nasdaq Gains Over 1%; Keurig Dr Pepper Earnings Top Views
8 months ago benzinga.com
Larimar Therapeutics (LRMR) Surges On FDA Breakthrough Therapy Designation
Larimar Therapeutics Inc (NASDAQ: LRMR) shares are trading sharply higher Tuesday after the company said the U.S. Food and Drug Administration granted Breakthrough Therapy Designation to its…
8 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
12 Health Care Stocks Moving In Tuesday's Intraday Session
8 months ago benzinga.com
Dow Gains Over 100 Points; Home Depot Posts Upbeat Earnings
Dow Gains Over 100 Points; Home Depot Posts Upbeat Earnings
11 months ago benzinga.com
Top 3 Health Care Stocks That May Rocket Higher In December
Top 3 Health Care Stocks That May Rocket Higher In December
-
12 months ago benzinga.com
Larimar Therapeutics Q3 EPS $(0.61) Misses $(0.40) Estimate
Larimar Therapeutics (NASDAQ:LRMR) reported quarterly losses of $(0.61) per share which missed the analyst consensus estimate of $(0.40) by 51.36 percent. This is a 154.17 percent decrease over…
1 year ago benzinga.com
Quantum Computing, Mesoblast And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Quantum Computing, Mesoblast And Other Big Stocks Moving Lower In Monday's Pre-Market Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session
12 Health Care Stocks Moving In Wednesday's Intraday Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers cbdMD (AMEX:YCBD) shares rose 116.3% to $1.35 during Monday's regular session. The company's market cap stands at $5.5 million. Zura Bio (NASDAQ: ZURA) stock moved upwards by 42.94% to $3.44.…
1 year ago benzinga.com
Why Merus Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket
Shares of Merus NV (NASDAQ: MRUS) rose sharply in today's pre-market trading. Genmab announced plans to acquire Merus for $8 billion in all-cash deal adding breakthrough therapy Petosemtamab to its…
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
12 Health Care Stocks Moving In Tuesday's After-Market Session
1 year ago benzinga.com
This MicroStrategy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
This MicroStrategy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session
12 Health Care Stocks Moving In Monday's Pre-Market Session
-
1 year ago benzinga.com
Crude Oil Down 1%; Webuy Global Shares Spike Higher
Crude Oil Down 1%; Webuy Global Shares Spike Higher
-
2 years ago benzinga.com
G-III Apparel Posts Upbeat Results, Joins NIO, Yext, Shoe Carnival And Other Big Stocks Moving Higher On Thursday
G-III Apparel Posts Upbeat Results, Joins NIO, Yext, Shoe Carnival And Other Big Stocks Moving Higher On Thursday
-
2 years ago benzinga.com
Why SentinelOne Shares Are Trading Lower By 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Why SentinelOne Shares Are Trading Lower By 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session
-
2 years ago benzinga.com
Ambarella Posts Upbeat Results, Joins Gap, PagerDuty, Elastic And Other Big Stocks Moving Higher On Friday
Ambarella Posts Upbeat Results, Joins Gap, PagerDuty, Elastic And Other Big Stocks Moving Higher On Friday
-
2 years ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session
12 Health Care Stocks Moving In Wednesday's Intraday Session
-
2 years ago benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
12 Health Care Stocks Moving In Tuesday's After-Market Session
-
2 years ago benzinga.com
Why IPG Photonics Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of IPG Photonics Corporation (NASDAQ: IPGP) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter financial results and issued soft first-quarter guidance.
-
2 years ago benzinga.com
Why Big Lots Shares Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Big Lots, Inc. (NYSE: BIG) fell sharply during Monday’s session after the company reported preliminary fourth-quarter results. Also, Loop Capital downgraded the stock from Hold to Sell and…
-
4 years ago benzinga.com
Why Karuna Therapeutics Jumped Around 72%; Here Are 96 Biggest Movers From Yesterday
Gainers Helbiz, Inc. (NASDAQ: HLBZ) jumped 114.6% to close at $1.61 on Monday after climbing over 27% on Friday.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Thursday
On Thursday, 108 companies set new 52-week lows.